How one CDMO navigated the pandemic: Adversity, Adaption, Delivery, Expansion. Though we are now well past the two-year COVID mark, the impact of the ordeal has changed the ways CDMO companies “think” and function. expertXchange November 1, 2022 More
Packaging of Biologics and Specialty Medicines: Planning for a Seamless Transition from Clinic to Launch. Article August 22, 2022 More
Optimizing Your Clinical Trial to Commercialization Journey. The average cost of a delayed new drug launch is $15 million per day Whitepaper July 15, 2022 More